Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 08.25.2025 - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
• 08.25.2025 - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
• 08.20.2025 - Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing
• 08.20.2025 - Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing
• 08.07.2025 - Second Quarter 2025 Earnings Conference Call
• 08.07.2025 - Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 08.07.2025 - Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 07.28.2025 - Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025

Recent Filings

• 08.25.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.20.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 8-K Current report
• 07.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.24.2025 - 3 Initial statement of beneficial ownership of securities